Interesting facts
Exploring 4-benzamido-5-(dipropylamino)-5-oxo-pentanoic acid
4-benzamido-5-(dipropylamino)-5-oxo-pentanoic acid is a fascinating compound with intriguing properties and potential applications. Here are some interesting facts about this chemical:
- Pharmaceutical Relevance: This compound may play a significant role in the pharmaceutical industry, particularly in drug design and development. Its unique structure is thought to contribute to various biochemical interactions.
- Structure and Function: The presence of the benzamido group enhances its ability to interact with biological systems, potentially improving its efficacy as a therapeutic agent.
- Biological Activity: Research suggests that compounds similar to this one can exhibit notable biological activity, which could include antimicrobial or anti-inflammatory properties.
- Amine Component: The dipropylamino part of the molecule is particularly noteworthy as it can affect the compound's solubility and permeability, influencing how the body absorbs and metabolizes it.
- Synthesis Considerations: The synthesis of this compound involves multiple steps and careful control of reaction conditions to ensure the desired functional groups are preserved.
In summary, 4-benzamido-5-(dipropylamino)-5-oxo-pentanoic acid is not just a chemical compound, but a potential catalyst for medical advancement. As scientists continue to explore its properties, it could lead towards new therapies and a deeper understanding of biochemical processes.
Synonyms
proglumide
6620-60-6
4-benzamido-5-(dipropylamino)-5-oxopentanoic acid
Binoside
Xylamide
Nulsa
Gastrotopic
Midelid
Ulcutin
dl-proglumide
Milid
Proglumida
Proglumidum
Milide
Xyde
Pentanoic acid, 4-(benzoylamino)-5-(dipropylamino)-5-oxo-
Promid
Proglumidum [INN-Latin]
Proglumida [INN-Spanish]
Promide (parasympatholytic)
W-5219
CR 242
Xylamide (gastroprotective agent)
EINECS 229-567-4
242 DL
CR-242
W 5219
NSC-757841
BRN 4151696
EPL8W5565D
Nulsa (TN)
DTXSID7023516
CHEBI:32058
Pentanoic acid, 4-(benzoylamino)-5-(dipropylamino)-5-oxo-, (+-)-
4-(benzoylamino)-5-(dipropylamino)-5-oxopentanoic acid
Proglumide [USAN:INN:BAN:JAN]
PROGLUMIDE [MI]
PROGLUMIDE [INN]
PROGLUMIDE [JAN]
(+-)-4-Benzamido-N,N-dipropylglutaramic acid
PROGLUMIDE [USAN]
Glutaramic acid, 4-benzamido-N,N-dipropyl-, DL-
PROGLUMIDE [MART.]
PROGLUMIDE [WHO-DD]
CHEMBL316561
DTXCID003516
NSC 757841
Proglumidum (INN-Latin)
Proglumida (INN-Spanish)
PROGLUMIDE (MART.)
24485-90-3
Xilamide
SR-01000002970
UNII-EPL8W5565D
racemic proglumide
(RS)-proglumide
Proglumide,(S)
NCGC00016676-01
(+-)-proglumide
4-(Benzoylamino)-5-(dipropylamino)-5-oxo-pentanoic acid;DL-4-Benzamido-N,N-dipropylglutaramic acid;(+/-)-Proglumide
Prestwick_602
CAS-6620-60-6
MFCD00055071
Spectrum_001332
DL-4-benzamido-N,N-dipropylglutaramic acid
Prestwick0_000240
Prestwick1_000240
Prestwick2_000240
Prestwick3_000240
Spectrum2_001406
Spectrum3_001444
Spectrum4_000425
Spectrum5_001591
(+/-)-4-Benzamido-N,N-dipropylglutaramic acid
Lopac0_000832
SCHEMBL93339
BSPBio_000319
BSPBio_002907
GTPL893
KBioGR_000750
KBioSS_001812
MLS002154246
DivK1c_000684
SPECTRUM1501119
SPBio_001452
SPBio_002240
4-(Benzoylamino)-5-(dipropylamino)-5-oxovaleric acid
BPBio1_000351
Proglumide - Bio-X trade mark
Proglumide (JP17/USAN/INN)
SCHEMBL19994752
CHEBI:76266
HMS502C06
KBio1_000684
KBio2_001812
KBio2_004380
KBio2_006948
KBio3_002407
A02BX06
NINDS_000684
HMS1568P21
HMS1921F19
HMS2092D13
HMS2095P21
HMS2235B24
HMS3262H05
HMS3369D14
HMS3712P21
Pharmakon1600-01501119
HY-B1330
Tox21_110557
Tox21_500832
BDBM50014888
CCG-39024
NSC757841
Pentanoic acid, 4-(benzoylamino)-5-(dipropylamino)-5-oxo-, (.+-.)-
AKOS015895810
Tox21_110557_1
AC-1274
CS-8029
DB13431
FP27175
KS-1212
LP00832
SDCCGSBI-0050809.P004
4-Benzamido-N,N-dipropylglutaramic acid
IDI1_000684
NCGC00015623-03
NCGC00015623-04
NCGC00015623-05
NCGC00015623-06
NCGC00015623-07
NCGC00015623-10
NCGC00015623-14
NCGC00094163-01
NCGC00094163-02
NCGC00094163-03
NCGC00094163-04
NCGC00261517-01
BP166197
DA-66886
SMR001233513
SBI-0050809.P003
N(2)-benzoyl-N,N-dipropyl-alpha-glutamine
AB00052206
EU-0100832
M-001
NS00004778
N2-(phenylcarbonyl)-N,N-dipropyl-a-glutamine
4-Benzoylamino-4-dipropylcarbamoyl-butyric acid
D01818
G12126
rac-N(2)-benzoyl-N,N-dipropyl-alpha-glutamine
AB00052206_08
4-Benzoylamino-5-dipropylamino-5-oxopentanoic acid
N~2~-(phenylcarbonyl)-N,N-dipropyl-alpha-glutamine
Q7248362
SR-01000002970-2
SR-01000002970-4
SR-01000002970-7
BRD-A44863528-001-05-8
BRD-A44863528-001-08-2
BRD-A44863528-001-13-2
4-(Benzoylamino)-5-(dipropylamino)-5-oxo-pentanoic Acid
PENTANOIC ACID, 4-(BENZOYLAMINO)-5-(DIPROPYLAMINO)-5-OXO-, (+/-)-
229-567-4
Solubility of 4-benzamido-5-(dipropylamino)-5-oxo-pentanoic acid
The solubility of 4-benzamido-5-(dipropylamino)-5-oxo-pentanoic acid (C19H22N2O4), a complex organic compound, can be influenced by several factors. Given its molecular structure, this compound exhibits unique solubility characteristics, which can generally be summarized as follows:
Overall, while definitive solubility data may vary, it is likely that 4-benzamido-5-(dipropylamino)-5-oxo-pentanoic acid exhibits increased solubility in organic solvents as opposed to aqueous solutions. Understanding these solubility properties is vital for applications in pharmaceuticals and chemical research.